HeLa Ser/Thr Phosphatase-Inhibited Whole Cell Lysate Set: Calyculin-Treated and Vehicle-Treated
Be the first to review this product! Submit a review
|
(0 Publication)
- WB
Supplier Data
Western blot - HeLa Ser/Thr Phosphatase-Inhibited Whole Cell Lysate Set: Calyculin-Treated and Vehicle-Treated (AB135395)
Western Blot.
All lanes : Anti-Phosphoserine/Threonine antibody (ab17464) at 1/1000
Lane 1 : Marker
Lane 2 : HeLa Whole Cell Lysate - Calyculin Treated at 20 μg
Lane 3 : HeLa Whole Cell Lysate – Untreated Control at 20 μg
Secondary :
Goat polyclonal to Rabbit IgG – Pre-Adsorbed (HRP) at 1/6000 developed using the ECL technique.
Performed under reducing conditions.
false
- SDS-PAGE
Supplier Data
SDS-PAGE - HeLa Ser/Thr Phosphatase-Inhibited Whole Cell Lysate Set: Calyculin-Treated and Vehicle-Treated (AB135395)
SDS-PAGE. Lane 1 : Marker
Lane 2 : HeLa Whole Cell Lysate - Calyculin Treated at 20 µg
Lane 3 : HeLa Whole Cell Lysate – Untreated control at 20 µg
Gel
10-20% acrylamide separation gel
Reactivity data
Product details
HeLa whole cell extracts were collected in lysis buffer after 3 hour treatment with Calyculin A (50 nM) or vehicle (DMSO) in serum-free media. The protein content was determined by BCA assay. Calyculin A is a potent phosphatase inhibitor. Unlike Okadaic Acid, which only acts on protein phosphatase PP2A, Calyculin A inhibits both PP1 and PP2A. Cells treated with Calyculin A accumulate serine/threonine phosphorylation making them a strong positive control for phospho-threonine or phospho-serine specific antibodies.
Concentration:
HeLa Lysate - Vehicle Treated Control - 200 μg at 1 mg/mL
HeLa Lysate - Calyculin Treated - 200 μg at 1 mg/mL
The lysate is supplied in SDS-PAGE loading buffer with DTT and is ready to load on a gel.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com